Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity

Affiliations

Comment

Christopher K Rayner et al. JAMA. 2021.

. 2021 Sep 28;326(12):1213-1214.

doi: 10.1001/jama.2021.13021.

¹ Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.

No abstract available

Comment in

Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity-Reply.
Lingvay I, Garvey WT, Wadden TA. Lingvay I, et al. JAMA. 2021 Sep 28;326(12):1214-1215. doi: 10.1001/jama.2021.13024. JAMA. 2021. PMID: 34581743 No abstract available.

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, O'Neil PM, Rubino DM, Skovgaard D, Wallenstein SOR, Garvey WT; STEP 3 Investigators. Wadden TA, et al. JAMA. 2021 Apr 13;325(14):1403-1413. doi: 10.1001/jama.2021.1831. JAMA. 2021. PMID: 33625476 Free PMC article. Clinical Trial.